Abstract
Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Graphical Abstract
Current Drug Targets
Title:Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
Volume: 19 Issue: 6
Author(s): Paolo Boldrini*, Antonella Fusco, Ferdinando Nicoletti, Aldo Badiani and Luciano Saso
Affiliation:
- Department of Physiology and Pharmacology ,Italy
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Abstract: Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Export Options
About this article
Cite this article as:
Boldrini Paolo *, Fusco Antonella , Nicoletti Ferdinando , Badiani Aldo and Saso Luciano, Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450118666170425153356
DOI https://dx.doi.org/10.2174/1389450118666170425153356 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
5-(4-(2-[ F]fluoroethoxy)phenyl)-1-(2,4-dichlorophenyl)-4-cyano-N- (piperidin-1-yl)-1H-pyrazole-3-carboxamide ([ F]JHU88868), a Novel Radioligand for PET Imaging of Cannabinoid Type 1 Receptors
Current Radiopharmaceuticals Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis
Current Pharmaceutical Design Various Techniques for Measuring Physiological Parameters Using WSN: Current State of the Art and Challenges
International Journal of Sensors, Wireless Communications and Control Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Identification of Somatic Mutations in Dementia-related Genes in Cancer Patients
Current Alzheimer Research Commentary
CNS & Neurological Disorders - Drug Targets Paradoxes of Symmetry: Homochirality; Cryptochiral Reactions; Chiral Field, Memory, and Induction; Chiral and Racemic Environment
Current Organic Chemistry Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets Medical and Veterinary Importance of the Moonlighting Functions of Triosephosphate Isomerase
Current Protein & Peptide Science Similar Mechanisms Regulated by γ-Secretase are Involved in Both Directions of the Bi-Directional Notch-Delta Signaling Pathway as well as Play a Potential Role in Signaling Events Involving Type 1 Transmembrane Proteins
Current Stem Cell Research & Therapy Recent Developments in Cholinesterases Inhibitors for Alzheimers Disease Treatment
Current Medicinal Chemistry In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application
Current Drug Delivery Novel Strategies for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment
Current Alzheimer Research Editorial (Thematic Issue: Genetics: A Window into the Biology of the Mind)
Current Psychiatry Reviews Enzyme Inhibition and Induction in Liver Disease
Current Clinical Pharmacology Microwave-assisted Olefin Metathesis as Pivotal Step in the Synthesis of Bioactive Compounds
Current Medicinal Chemistry ‘Non-Criteria’ Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered
CNS & Neurological Disorders - Drug Targets